The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

A series of studies have raised concerns by associating synthetic food colorings with health risks from hyperactivity to ...

U.S. health agencies announced that the food industry will begin "phasing out" eight artificial food dyes in the coming years ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

That’s more than 13 percent of all global heart disease deaths that year. For their research, the study authors looked at ...

Future of Healthcategory· April 18, 2025 Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster ...

An urgent recall has been issued for a bread brand sold throughout the U.S. that could contain "glass fragments," according ...